Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevirimat functional monotherapy in HIV
NCT00511368Phase 2Completed
- Sponsor
- Myrexis, Inc.
- Start
- Apr 2006
- Primary completion
- Jul 2008
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bevirimat in human immunodeficiency virus infection (HIV), sponsored by Myrexis, Inc.. Started Apr 2006; status: completed.
02
Drugs
bevirimat
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00511368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00511368.